UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046918
Receipt number R000053530
Scientific Title PRP treatment combined with tendon repair and early functional rehabilitation for Achilles tendon rupture in athletes
Date of disclosure of the study information 2022/03/01
Last modified on 2024/08/19 12:18:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

PRP treatment combined with tendon repair for Achilles tendon rupture in athletes

Acronym

PRP treatment for Achilles tendon rupture in athletes

Scientific Title

PRP treatment combined with tendon repair and early functional rehabilitation for Achilles tendon rupture in athletes

Scientific Title:Acronym

PRP treatment combined with tendon repair for Achilles tendon rupture in athletes

Region

Japan


Condition

Condition

Achilles tendon rupture

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to prospectively investigated the clinical results of PRP treatment combined with postoperative early functional rehabilitation for Achilles tendon rupture in athletes

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the rate of return to sports until 6 months after intervention

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Tendon repair, PRP(3 ml) injection, tendon biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1.patients who is scheduled to receive operative treatment for Achilles tendon rupture
2.athletes
3.patients who is scheduled to receive early functional rehabilitation after operation
4.patients aged sixteen and over and patients aged under sixty-five

Key exclusion criteria

1.patients who received steroid therapy
2.re-rupture case
3.patients who previously received operative treatment of Achilles tendon
4.patients who could not undergo MRI examination
5.patients who is judged unsuitable by investigator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Toshito
Middle name
Last name Yasuda

Organization

Osaka Medical and Pharmaceutical University

Division name

Faculty of nursing

Zip code

569-0095

Address

7-6, Hatchonishi-machi, takatsuki City, Osaka, Japan

TEL

072-684-7267

Email

toshito.yasuda@ompu.ac.jp


Public contact

Name of contact person

1st name Toshito
Middle name
Last name Yasuda

Organization

Osaka Medical and Pharmaceutical University

Division name

Faculty of nursing

Zip code

569-0095

Address

7-6, Hatchonishi-machi, takatsuki City, Osaka, Japan

TEL

072-684-7267

Homepage URL


Email

toshito.yasuda@ompu.ac.jp


Sponsor or person

Institute

Osaka Medical and Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

Ministry of education, culture, sports, science and technology-Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee, Osaka Medical and Pharmaceutical University

Address

2-7, Daigaku-machi, takatsuki City, Osaka 569-8686, Japan

Tel

072-683-1221

Email

rinri@ompu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

3

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

none

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 11 Month 04 Day

Date of IRB

2022 Year 03 Month 22 Day

Anticipated trial start date

2022 Year 04 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 02 Month 15 Day

Last modified on

2024 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053530